The global brain pacemaker market is valued at USD 1,140.70 Million in 2018 and is expected to reach USD 3,740.81 Million by 2026, at a CAGR of 15.9 % from 2019 to 2026.
New York, NY -- (SBWIRE) -- 04/23/2021 -- The rise in prevalence of neurological disorders like Parkinson's disease, Alzheimer's, dementia and other neurological disorders are the major growth factors for brain pacemakers market.
According to the current analysis of Reports and Data, the global Brain Pacemakers market is expected to reach USD 3,740.81 million by the year 2026, in terms of value at a CAGR of 15.9%. Brain pacemaker is a neurostimulator, having an ability to send electrical impulses, through implanted electrodes, to specific targets in the brain for the treatment of neurological disorders. Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of brain pacemakers to treat neurological disorders. Increasing healthcare expenditure investments in the market, which augment the technological advancements in brain pacemakers are estimated to shape the growth of the brain pacemaker market. These advancements include enhanced microelectrode designs, robot-assisted implantation, multi-target stimulation, integrated implantable pulse generators, individualized directed programming, and magnetic resonance imaging (MRI). Due to the technological advancements in recent times, brain pacemakers have demonstrated lesser adverse effects and greater efficacy and symptomatic relief in patients with movement disorders as compared to conventional methods. Also, the potential benefits of deep brain stimulation therapy, such as better management of postoperative outcomes and long-term efficacy, are projected to facilitate growth of the brain pacemaker market over the forecast period. Furthermore, these advancements aid clinical researchers and physicians in investigational efficacy studies for the usage of Deep brain stimulation (DBS) in off-label clinical applications such as depression. However, high costs associated with brain pacemakers is anticipated to impede the market growth. Conversely, untapped potential of emerging economies such as China, India and Brazil is anticipated to provide attractive growth opportunities to the market players in the forecast period.
The major players in brain pacemaker market are PINS medical, Boston group, Abbott, and Medtronic, Aleva neurotherapeutics, and others.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1999
Key findings from the report suggest
- The single channel product type segment of global brain pacemaker market is expected to grow at a high CAGR by 2026. The significant share is due to the use & adoption of the single channel devices across different medical settings. This segment is observed to grow enormously in the study period
- Different products are anticipated to be launched in the analysis period in the brain pacemaker market. Abbot is anticipated to improve on its its St. Jude medical infinity
- Along with groundbreaking technology to help Parkinson's, this system uses a wireless IOS device (an Apple iPod) to control stimulation. It is a feature allows patients to receive discreet, personalized treatment in the palm of their hand.
- The handheld programmer will enable to control how much or how little stimulation the patient needs, which is another breakthrough to enhance patient care.
- Clinical evidence from the INTREPID study reported that patients treated with the Vercise System sustained a 48% improvement in motor function as measured by the Unified Parkinson's Disease Rating Scale (UPDRS).
- The three major manufacturers of brain pacemaker focused on neurology and had approximately $1billion in combined sales in the most recent reported quarter. Medtronic's brain therapies group is the leader, with $522 million in sales in the most recent quarter, though it does not break out DBS sales specifically. Abbott's neuromodulation unit had $300 million in global sales, with approximately 10% coming from DBS sales, but it says DBS has been growing since its launch in the U.S. last year.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/brain-pacemaker-market
Market segmentation:
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the industry trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the brain pacemaker market into product types, application types, sales channel, end user type and region.
Based on the product: (Revenue, USD Million; 2016-2026):
Single Channel
Dual Channel
Based on Applications (Revenue, USD Million; 2016-2026):
Parkinson's Disease
Epilepsy
Dystonia
Alzheimer's
Essential Tremor
Obsessive-Compulsive Disorder
Based on the end-user: (Revenue, USD Million; 2016-2026)
Hospitals
Ambulatory Surgical Centers & Clinics
Others
Based on the Sales channel (Revenue, USD Million; 2016-2026)
Channel sales
Direct sales
Based on Region (Revenue, USD Million; 2016-2026)
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Request for Customization: @ https://www.reportsanddata.com/request-customization-form/1999
Table of Content:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2016 – 2026
Chapter 3. Indicative Metrics
Chapter 4. Brain Pacemakers Segmentation & Impact Analysis
4.1. Brain Pacemakers Segmentation Analysis
4.2. Pharmaceutical Industry Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rise in prevalence of neurological disorders
4.2.3. Market restraints analysis
4.2.3.1. High cost
4.3. Regulatory Framework
4.4. ETOP Analysis
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
….
Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Mergers & Acquisitions
10.3. Market positioning
10.4. Strategy Benchmarking
10.5. Vendor Landscape
Chapter 11. Company Profiles
11.1. PINS medicals
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Insights
11.1.4. Strategic Initiatives
11.2. Boston group
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Insights
11.2.4. Strategic Initiatives
11.3. Abbott
11.3.1. Product Insights
11.3.2. Strategic Initiatives
11.4. Medtronic Public Limited Company
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Insights
11.4.4. Strategic Initiatives
11.5. Aleva neurotherapeutics
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Insights
11.5.4. Strategic Initiatives
Continue….
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
Browse More Reports :
Point of Care Hemoglobin Analyzer Market Size
Machine Learning Market Share
Anhydrous Aluminium Chloride Market Trends
Anesthesia Monitors Market Growth
Processed Seafood & Seafood Processing Equipment Market Analysis
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com